MedPath
FDA Approval

Calcium Acetate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
June 1, 2021
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Calcium acetate(667 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

INVAGEN PHARMACEUTICALS, INC.

165104469

Manufacturing Establishments2

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

InvaGen Pharmaceuticals, Inc.

EXELAN PHARMACEUTICALS, INC.

INVAGEN PHARMACEUTICALS, INC.

080334903

Avema Pharma Solutions

EXELAN PHARMACEUTICALS, INC.

INVAGEN PHARMACEUTICALS, INC.

804087794

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Calcium Acetate

Product Details

NDC Product Code
76282-377
Application Number
ANDA203135
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
June 1, 2021
SODIUM LAURYL SULFATEInactive
Code: 368GB5141JClass: IACT
Code: Y882YXF34XClass: ACTIBQuantity: 667 mg in 1 1
SODIUM STEARYL FUMARATEInactive
Code: 7CV7WJK4UIClass: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBDClass: IACT
FD&C RED NO. 3Inactive
Code: PN2ZH5LOQYClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
GELATINInactive
Code: 2G86QN327LClass: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357Class: IACT
© Copyright 2025. All Rights Reserved by MedPath